Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos

Inward Investment
Return to: PBR Home | Inward Investment
Search Refinements
Search Results: Inward Investment
1-15 of 512 results
Next Generation of Lab Solutions
Workshops, lab tours, new products - Get a free analytica ticket.
Inward Investment > Press Releases
New WuXi Life Science to acquire WuXi PharmaTech for $3.3bn
Shanghai-based WuXi PharmaTech has entered into a merger agreement with New WuXi Life Science and its wholly owned subsidiary WuXi Merger, worth a total cash consideration of $3.3bn.
Inward Investment > News
Thomas Bachmann is new Chief Executive Officer of the Eppendorf Group
Thomas Bachmann became Chief Executive Officer of the Eppendorf Group on August 1, 2015. Following the departure of Eppendorf's previous CEO, the company's Chief Financial Officer, Detmar Ammermann, had exercised the function of Spokesman of the Management Board on an interim basis in addition to his responsibilities as CFO.
Inward Investment > Press Releases
Truly Parallel - Microbiology
| By Eppendorf
DASGIP® Bioreactor Systems for Microbiology.
Inward Investment > White Papers
Truly Parallel - Cell Culture
| By Eppendorf
DASGIP® Bioreactor Systems for Cell Culture Applications.
Inward Investment > White Papers
Product Brochure: Most Compact
| By Eppendorf
DASbox® Mini Bioreactor System for Cell Culture and Microbiology.
Inward Investment > White Papers
Evaluation of the BioFlo® 320 Process Capabilities
| By Eppendorf
This poster characterizes the capabilities of the BioFlo320 in terms of key process parameters including oxygen transfer rate (OTR), volumetric mass transfer coecient (kLa), tip speed, mixing time, and water consumption. These data enable quantitative analyses of bioprocess engineering parameters, thus allowing potential users to gain insight into the system’s cell culture and fermentation capabilities.
Inward Investment > White Papers
Taking the Strain
| By Eppendorf
Today, the rapidly expanding demand for vaccine products for viral diseases such as rabies has necessitated the development of more sophisticated production techniques based around cell culture systems. This article reviews vaccine production strategies, with a focus on rabies, looking specifically at the use of the Vero cell line - used worldwide and approved by the US Food and Drug Administration - as well as media technology and the bioreactor options available.
Inward Investment > White Papers
DASGIP® Control is now DASware® control 5 - Parallel Processing Advances Bioprocess Development
With DASware control 5 Eppendorf presents its revised software for benchtop bioprocess control. The updated graphical user interface provides intuitive process views, user-defined functions, and configurable charts.
Inward Investment > Press Releases
Growing Potential: mAb Production With Fibra-Cel
| By Eppendorf
The market for monoclonal antibodies continues to grow steadily, but there are still bottlenecks in the development of new products, including long development times mostly due to R&D. Advanced bioprocess equipment that meets the specific demands of mAb-producing hybridoma can accelerate design and production, and reduce overall development costs along the way.
Inward Investment > White Papers
DoE Bioprocess Development
| By Eppendorf
Eppendorf DASware is the effective route to design of experiments (DoE) in early-stage bioprocess development. Claudia M Huether-Franken and Sebastian Kleebank explain how the design software applies DoE to DASGIP parallel bioreactor systems.
Inward Investment > White Papers
Eppendorf and Florida State University Collaboration Demonstrates Large-Scale Stem Cell Expansion
A collaboration between Eppendorf and Florida State University has successfully shown the feasibility of large-scale expansion of human mesenchymal stem cells (MSC) using the company's proprietary Fibra-Cel® packed-bed technology.
Inward Investment > Press Releases
PPF Group acquires minority stake in Cytune Pharma
By PBR Staff Writer
PPF Group, in cooperation with SOTIO has completed acquisition of minority stake in French biotechnology firm Cytune Pharma.
Inward Investment > News

PBR Supplier Recommendations

Eppendorf - We Know Bioprocessing
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO² incubators, shakers, and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates, and disposable bioreactors complement the range of highest-quality premium products.... Inward Investment > Suppliers
Boehringer Ingelheim - Drug Substance and Drug Product Services
Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 145 affiliates in 50 countries and more than 42,000 employees. Since it was founded in 1885, the family-owned company has been committed for 125 years to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.... Inward Investment > Suppliers
MIDAS Manchester's Inward Investment Agency
MIDAS is Manchester’s inward investment agency and its specialist team offers a range of free, impartial bespoke services to businesses looking to set up or expand in Manchester. We have a reputation for understanding diverse business needs and help remove any barriers, making your relocation or expansion into Manchester as smooth and simple as possible. ... Inward Investment > Suppliers
Genoma España - Applied Genomics and Biotechnology Innovation
Genoma España was created in 2002 to improve the worldwide competitiveness of Spanish research on applied genomics.... Inward Investment > Suppliers
BioPartners - Developing Biologics, Delivering Patient Care
Established in 2000, Biopartners' aim is to be a leader in developing and commercialising innovative formulations and novel delivery systems of first-generation biopharmaceuticals for which there are substantial unmet medical/patients' needs.... Inward Investment > Suppliers
See more

PBR White Paper Recommendations

Truly Parallel - Microbiology By Eppendorf
DASGIP® Bioreactor Systems for Microbiology.... Inward Investment > White Papers Truly Parallel - Cell Culture By Eppendorf
DASGIP® Bioreactor Systems for Cell Culture Applications.... Inward Investment > White Papers Product Brochure: Most Compact By Eppendorf
DASbox® Mini Bioreactor System for Cell Culture and Microbiology.... Inward Investment > White Papers Product Brochure: The Smarter Solution By Eppendorf
BioFlo® 320 bioprocess control station.... Inward Investment > White Papers Evaluation of the BioFlo® 320 Process Capabilities By Eppendorf
This poster characterizes the capabilities of the BioFlo320 in terms of key process parameters including oxygen transfer rate (OTR), volumetric mass transfer coecient (kLa), tip speed, mixing time, and water consumption. These data enable quantitative analyses of bioprocess engineering parameters, thus allowing potential users to gain insight into the system’s cell culture and fermentation capabilities.... Inward Investment > White Papers See more
1-15 of 512 results